Coeptis Therapeutics Holdings, Inc. (COEP) Institutional Ownership

Ownership Summary

A total of 14 institutions have reported a stake in Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) as of December 2025, according to recent 13F filings with the SEC.

• Institutional ownership in Coeptis Therapeutics Holdings edged up to 17.5% in December 2025, compared to 5.5% in September 2025.
• On a quarter-over-quarter basis, institutional holdings shifted by 312.31%, with a year-over-year an increase of 75.00% in the count of filers.
• A review of institutional activity for Coeptis Therapeutics Holdings shows 11 of 14 filers increasing their positions, while 1 reduced their stake, and 2 remained unchanged.
• The total number of shares held by institutions in Coeptis Therapeutics Holdings increased to 458.16K as of December 2025, a net change of up by 347.04K shares quarter on quarter, and up 447.34K shares year over year.
• The top institutional stake in Coeptis Therapeutics Holdings as of December 31, 2025 belongs to VANGUARD GROUP INC, which owns 339.49K shares, or 12.97% of the company.
• Among the most significant buyers of Coeptis Therapeutics Holdings during December 2025 were VANGUARD GROUP INC (288.81K), MARSHALL WACE, LLP (18.19K), BlackRock, Inc. (13.57K), NORTHERN TRUST CORP (12.22K), STATE STREET CORP (6.96K).
• Leading sellers of Coeptis Therapeutics Holdings stock in December 2025 included PNC FINANCIAL SERVICES GROUP, INC. (225).
• The top 10 institutional holders of Coeptis Therapeutics Holdings for the quarter ending December 2025 included VANGUARD GROUP INC (339.49K), GEODE CAPITAL MANAGEMENT, LLC (42.10K), STATE STREET CORP (26.83K), MARSHALL WACE, LLP (18.19K), BlackRock, Inc. (13.57K), NORTHERN TRUST CORP (12.22K), Steward Partners Investment Advisory, LLC (5.00K), PNC FINANCIAL SERVICES GROUP, INC. (238), MORGAN STANLEY (200), UBS Group AG (193).